It's called Teriparatide, and it's been approved for the treatment of Osteoporosis in postmenopausal women who are at high risk for having a fracture. Daily injections of Teriparatide stimulate new bone formation leading to increased bone mineral density.
The drug is manufactured by Eli Lilly and Company of Indianapolis, Indiana and will be marketed under the trade name Forteo. For more information, you can (click here).
The drug is also approved to increase bone mass in men with primary or Hypogonadal Osteoporosis who are at high risk for fracture. Teriparatide is a portion of human parathyroid hormone which is the primary regulator of calcium and phosphate metabolism in bones.